title: Conclusive Article: Sorting the Good from the Bad: The Different Approaches to Predict Cognitive Properties of New Symptomatic Drug Candidates for Neurodegenerative Diseases in Early Development.
authors.forename: Julie
authors.initials: J
authors.lastname: Deguil
authors.forename: Alexandra
authors.initials: A
authors.lastname: Auffret
authors.forename: Esther
authors.initials: E
authors.lastname: Schenker
authors.forename: Fabienne
authors.initials: F
authors.lastname: Aujard
authors.forename: Yves
authors.initials: Y
authors.lastname: Lamberty
authors.forename: David
authors.initials: D
authors.lastname: Bartrès-Faz
authors.forename: María T
authors.initials: MT
authors.lastname: Herrero
authors.forename: Olivier
authors.initials: O
authors.lastname: Blin
authors.forename: Joëlle
authors.initials: J
authors.lastname: Micallef
authors.forename: Jill C
authors.initials: JC
authors.lastname: Richardson
authors.affiliation: Department of Pharmacology, University Lille Nord de France, Lille, France. julie.deguil@univ-lille2.fr.
authors.forename: Régis
authors.initials: R
authors.lastname: Bordet
mesh_terms: D003072:Cognition Disorders / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D019636:Neurodegenerative Diseases / Q000150:complications / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011237:Predictive Value of Tests
chemical_list: D018696:Neuroprotective Agents